{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:42:12Z","timestamp":1786372932438,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>In animal models of polycystic kidney disease, the ingestion of large amounts of water promotes diuresis by suppressing plasma levels of arginine vasopressin (AVP) and renal levels of cAMP, slowing cyst progression. Whether simple water ingestion is a potential therapeutic strategy for individuals with autosomal dominant polycystic kidney disease (ADPKD) is unknown. In this study, a simple method to quantify the amount of water to achieve a specific mean urine osmolality target in patients with ADPKD was developed and tested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>In eight ADPKD patients eating typical diets, osmolality and volume were measured in 24-hour urine collections. The amount of additional ingested water required daily to achieve a mean urine osmolality of 285 \u00b1 45 mosm\/kg was determined. Participants were instructed to distribute the prescribed water over waking hours for each of 5 days. Blood chemistries, 24-hour urine collections, BP, and weight were measured before and after the period of supplemental water intake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five patients achieved the 285 mosm\/kg urine target without difficulty. Mean urine osmolality decreased and mean urine volume increased; serum sodium, weight, and BP were unchanged. Daily osmolar excretion remained constant, indicating a stable\n                      <jats:italic toggle=\"yes\">ad lib<\/jats:italic>\n                      dietary intake of solutes and protein over the 2-week study period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The amount of additional water needed to achieve a urine osmolality target can be approximated from the urine osmolar excretion in ADPKD patients eating typical diets, providing a quantitative method to prescribe supplemental water for such individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.03950510","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T20:55:35Z","timestamp":1285707335000},"page":"192-197","source":"Crossref","is-referenced-by-count":71,"title":["Water Prescription in Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.2215","volume":"6","author":[{"given":"Connie J.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Creed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz T.","family":"Winklhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared J.","family":"Grantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20230811","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2215\/CJN.00330705","article-title":"Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes","volume":"1","author":"Grantham","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R2-26-20230811","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1523-1755.2003.00242.x","article-title":"Lillian Jean Kaplan International Prize for advancement in the understanding of polycystic kidney disease. Understanding polycystic kidney disease: A systems biology approach","volume":"64","author":"Grantham","year":"2003","journal-title":"Kidney Int"},{"key":"R3-26-20230811","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2215\/CJN.00790209","article-title":"A case for water in the treatment of polycystic kidney disease","volume":"4","author":"Torres","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-26-20230811","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","article-title":"Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease","volume":"24","author":"Gattone","year":"1999","journal-title":"Dev Genet"},{"key":"R5-26-20230811","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"R6-26-20230811","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1681\/ASN.2006030251","article-title":"Increased water intake decreases progression of polycystic kidney disease in the PCK rat","volume":"17","author":"Nagao","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R7-26-20230811","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-5347(01)66321-3","article-title":"Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: A 5-year randomized prospective study","volume":"155","author":"Borghi","year":"1996","journal-title":"J Urol"},{"key":"R8-26-20230811","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000046296","article-title":"Urine volume: Stone risk factor and preventive measure","volume":"81","author":"Borghi","year":"1999","journal-title":"Nephron"},{"key":"R9-26-20230811","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/00039896.1966.10664630","article-title":"Prevention of urolithiasis. Education to adequate fluid intake in a new town situated in the Judean Desert Mountains","volume":"13","author":"Frank","year":"1966","journal-title":"Arch Environ Health"},{"key":"R10-26-20230811","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0090-4295(02)01631-X","article-title":"Calcium nephrolithiasis: Effect of water hardness on urinary electrolytes","volume":"60","author":"Schwartz","year":"2002","journal-title":"Urology"},{"key":"R11-26-20230811","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2215\/CJN.03401006","article-title":"Ethnic differences in urine concentration: possible relationship to blood pressure","volume":"2","author":"Bankir","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-26-20230811","doi-asserted-by":"crossref","first-page":"R700","DOI":"10.1152\/ajpregu.00500.2006","article-title":"Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease","volume":"292","author":"Perucca","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R13-26-20230811","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2215\/CJN.04180609","article-title":"A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease","volume":"5","author":"Barash","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R14-26-20230811","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"R15-26-20230811","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1046\/j.1523-1755.2001.00746.x","article-title":"Twenty-four-hour urine chemistries and the risk of kidney stones among women and men","volume":"59","author":"Curhan","year":"2001","journal-title":"Kidney Int"},{"key":"R16-26-20230811","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ki.1989.38","article-title":"The clinical utility of renal concentrating capacity in polycystic kidney disease","volume":"35","author":"Gabow","year":"1989","journal-title":"Kidney Int"},{"key":"R17-26-20230811","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/clinchem\/33.6.847","article-title":"Biological variation in analyte concentrations in urine of apparently healthy men and women","volume":"33","author":"Gowans","year":"1987","journal-title":"Clin Chem"},{"key":"R18-26-20230811","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/ajkd.2000.8266","article-title":"Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease","volume":"36","author":"Grampsas","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R19-26-20230811","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/clinchem\/40.3.472","article-title":"Biological variation in urine samples used for analyte measurements","volume":"40","author":"Ricos","year":"1994","journal-title":"Clin Chem"},{"key":"R20-26-20230811","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/clinchem\/27.4.569","article-title":"Short- and long-term biological variation in analytes in urine of apparently healthy individuals","volume":"27","author":"Shephard","year":"1981","journal-title":"Clin Chem"},{"key":"R21-26-20230811","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2215\/CJN.00910306","article-title":"Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease","volume":"2","author":"Torres","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R22-26-20230811","first-page":"294A","article-title":"Recurrent stone formers failed to increase urine volume significantly over a 3-y period in spite of recommendations to more, and still showed a higher Tiselius index in morning urine","volume":"19","author":"Bankir","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R23-26-20230811","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.nephro.2007.11.003","article-title":"[Difference in urine concentration according to gender and ethnicity: Possible involvement in the different susceptibility to various renal and cardiovascular diseases]","volume":"4","author":"Perucca","year":"2008","journal-title":"Nephrol Ther"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201101000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:16Z","timestamp":1786369216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201101000-00026"}},"subtitle":["A Pilot Study"],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.03950510","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}